• Peanuts are the most common fatal allergic reaction of food origin in the United States and other Western countries.

 

  • Sensitization to peanuts may confer greater risk for allergic reaction upon subsequent and continued consumption, however, a large percentage of patients with sensitization do not experience allergic symptoms.

 

  • The Vibrant Peanut Allergy Component test can definitively answer whether your patient has or is at risk for mild, moderate, or severe peanut allergies. This can eliminate doubt and aid in rapid dietary modifications for allergy management.

 

  • Peanut allergy component testing may be ordered with the Vibrant Peanut Zoomer in order to test for the full spectrum of reactivity to peanuts – from mild sensitivity to severe high risk anaphylaxis. The Vibrant Peanut Allergy Component test covers all IgE reactions to peanuts, while the Vibrant Peanut Zoomer covers IgG and IgA reactions, which are less severe, but can still produce uncomfortable symptoms in sensitive patients.

 

Not Available in New York state
Only healthcare providers licensed in their state may order laboratory testing.

Peanut Component

$150.00Price
  • Ara h 1

    Reactivity to Ara h 1, Ara h 2, Ara h 3 or Ara h 6 is associated with a high risk for systemic reaction, including anaphylaxis.

    Ara h 2

    Reactivity to Ara h 1, Ara h 2, Ara h 3 or Ara h 6 is associated with a high risk for systemic reaction, including anaphylaxis. Ara h 2 is the marker of clinical peanut allergy most strongly associated with severe and anaphylactic reactions to peanuts.

    Ara h 3

    Reactivity to Ara h 1, Ara h 2, Ara h 3 or Ara h 6 is associated with a high risk for systemic reaction, including anaphylaxis.

    Ara h 6

    Reactivity to Ara h 1, Ara h 2, Ara h 3 or Ara h 6 is associated with a high risk for systemic reaction, including anaphylaxis. Ara h 6 is most often seen in cross-reactivity to Ara h 2.

    Ara h 8

    Reactivity to Ara h 8 and nonreactivity to Ara h 1, 2, 3, and 9 indicates a low risk of a systemic allergic reaction. Symptoms tend to be mild and localized, rather than systemic.

    Ara h 9

    Reactivity to Ara h 9 is associated with a variable risk for systemic reaction, including anaphylaxis.